Ceragenix has a solid pipeline of products based on its skin barrier repair and Ceragenin technologies. All of these products are surface active, having a therapeutic effect on the skin, at the interface of the skin or tissues and the surface of medical devices, or on the epithelium as in the case of CGX-313 -- a product for the reduction of bacterial colonization in the nose. The products, their current stage of development and regulatory pathway are summarized in the chart below.